Journal of Clinical Endocrinology & Metabolism, Vol 46, 236-246, Copyright © 1978 by Endocrine Society

ARTICLES

Combined 17 alpha- and 18-hydroxylase deficiency associated with complete male pseudohermaphroditism and hypoaldosteronism

W Waldhausl, K Herkner, P Nowotny and P Bratusch-Marrain

A 15-year-old phenotypic female with XY genotype presented with male pseudohermaphroditism, gynecomastia, hypokalemic alkalosis, and hypertension. Being raised as a girl, the patient failed to menstruate and developed no sexual hair. At laparatomy no Mullerian structures were found but testes were removed which showed histologically atrophy of seminiferous tubules and abundant Leydig cells. Deoxycorticosterone (2.0 mg/24 h) and corticosterone (117 mg/24 h) secretion rates were extremely elevated, whereas those of aldosterone (17 micrograms/24 h), deoxycortisol (22 micrograms/24 h), and cortisol (23 micrograms/24 h) were almost unmeasurable. The excretion rates of 18-OH- deoxycorticosterone (less than 0.25 microgram/24 h) and 18-OH- corticosterone (3.0 microgram/24 h) were subnormal in spite of high plasma ACTH levels (200 pg/ml), and deoxycorticosterone (32.2 micrograms/24 h) and corticosterone (269 micrograms/24 h) excess. Gonadotropins were elevated. Deficient 17 alpha-hydroxylation was suspected because of: 1) low levels of 17 alpha-OH-progesterone; 2) diminished excretion rates of both 17 alpha-OH-progesterone and pregnanetriol; and 3) reduced concentrations of dehydroepiandrosterone, androstenedione, and testosterone in testicular tissue. We conclude that this male pseudohermaphrodite with complete female phenotype had 17 alpha-hydroxylase deficiency. The enzymatic defect was linked with an associated 18-hydroxylase deficiency.

This article has been cited by other articles:

				M. Krebs, B. Brunmair, A. Brehm, M. Artwohl, J. Szendroedi, P. Nowotny, E. Roth, C. Furnsinn, M. Promintzer, C. Anderwald, et al. The Mammalian Target of Rapamycin Pathway Regulates Nutrient-Sensitive Glucose Uptake in Man Diabetes, June 1, 2007; 56(6): 1600 - 1607. [Abstract] [Full Text] [PDF]

				F. Tremblay, M. Krebs, L. Dombrowski, A. Brehm, E. Bernroider, E. Roth, P. Nowotny, W. Waldhausl, A. Marette, and M. Roden Overactivation of S6 Kinase 1 as a Cause of Human Insulin Resistance During Increased Amino Acid Availability Diabetes, September 1, 2005; 54(9): 2674 - 2684. [Abstract] [Full Text] [PDF]

				S. M. Baumgartner-Parzer, P. Nowotny, W. Waldhausl, and H. Vierhapper A Rare Duplicated 21-Hydroxylase Haplotype and a de Novo Mutation: A Family Analysis J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2794 - 2796. [Abstract] [Full Text] [PDF]

				H. Stingl, W. J. Schnedl, M. Krssak, E. Bernroider, M. G. Bischof, T. Lahousen, G. Pacini, and M. Roden Reduction of Hepatic Glycogen Synthesis and Breakdown in Patients with Agenesis of the Dorsal Pancreas J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4678 - 4685. [Abstract] [Full Text] [PDF]

				M. Krebs, M. Krssak, E. Bernroider, C. Anderwald, A. Brehm, M. Meyerspeer, P. Nowotny, E. Roth, W. Waldhausl, and M. Roden Mechanism of Amino Acid-Induced Skeletal Muscle Insulin Resistance in Humans Diabetes, March 1, 2002; 51(3): 599 - 605. [Abstract] [Full Text] [PDF]

				M. G. Bischof, E. Bernroider, M. Krssak, M. Krebs, H. Stingl, P. Nowotny, C. Yu, G. I. Shulman, W. Waldhausl, and M. Roden Hepatic Glycogen Metabolism in Type 1 Diabetes After Long-Term Near Normoglycemia Diabetes, January 1, 2002; 51(1): 49 - 54. [Abstract] [Full Text] [PDF]